Literature DB >> 3439886

Cholinesterases in blood plasma and tissues of rats treated with n-hexane or with its neurotoxic metabolite 2,5-hexanedione.

A Bastone1, N Frontali, C Mallozzi, M Sbraccia, L Settimi.   

Abstract

Adult male rats were subjected to 4 weeks' respiratory treatment with n-hexane (5000 ppm, 16h/day, 6 days/week); motor conduction velocity was significantly decreased in tail nerves at all weekly intervals and did not approach normal values in the 4 weeks following interruption of treatment. Plasma acetylcholinesterase (AChE) levels were significantly increased at all weekly intervals during treatment (25-40%); 2 weeks after the end of treatment they had returned to baseline. Oral treatment with 2,5-hexanedione (HD) (1% in drinking water) caused a similar increase in plasma levels; this increase was statistically significant also when compared with pair-fed (PF) control rats. A sucrose density gradient analysis showed only one peak of AChE activity at approximately 10 S (as in normal plasma). The levels of butyrylcholinesterase were unaltered in plasma of both n-hexane-and HD-treated rats. Both the fast-contracting EDL and the slow-contracting soleus muscles lost weight in HD-treated rats with respect to free-fed (AL) and PF controls. AChE levels responded differently to HD treatment in the two muscle types: in EDL total extracts, AChE activity increased considerably with respect to AL controls (+ 70%, p less than 0.001), while the levels of the 16 S and 4 S molecular forms were unaltered. The increased levels of AChE found in plasma of rats intoxicated with n-hexane or with its metabolite HD may originate from muscle and correspond to an increased secretion of this molecular form.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439886     DOI: 10.1007/BF00661372

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  40 in total

1.  SIMPLIFIED "DISC" (POLYACRYLAMIDE GEL) ELECTROPHORESIS.

Authors:  J T CLARKE
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Polyneuropathy due to n-hexane.

Authors:  G W Paulson; G W Waylonis
Journal:  Arch Intern Med       Date:  1976-08

3.  n-Hexane polyneuropathy.

Authors:  Y Yamamura
Journal:  Folia Psychiatr Neurol Jpn       Date:  1969

4.  Effect of denervation on the molecular forms of acetylcholinesterase in normal and dystrophic chicken muscles.

Authors:  J Sketelj; M G McNamee; B W Wilson
Journal:  Exp Neurol       Date:  1978-07       Impact factor: 5.330

Review 5.  The enlarging view of hexacarbon neurotoxicity.

Authors:  P S Spencer; H H Schaumburg; M I Sabri; B Veronesi
Journal:  Crit Rev Toxicol       Date:  1980-10       Impact factor: 5.635

6.  Neurotoxic effects of 2,5-hexanedione in rats: early morphological and functional changes in nerve fibres and neuromuscular junctions.

Authors:  A Cangiano; L Lutzemberger; N Rizzuto; A Simonati; A Rossi; G Toschi
Journal:  Neurotoxicology       Date:  1981-01       Impact factor: 4.294

7.  Acetylcholinesterase activity and molecular forms during denervation and reinnervation in extensor digitorum longus muscle of the rat.

Authors:  M I Senni; S Biagioni; P Marini; G Scarsella
Journal:  Neurochem Res       Date:  1981-12       Impact factor: 3.996

Review 8.  Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments.

Authors:  L M Sayre; L Autilio-Gambetti; P Gambetti
Journal:  Brain Res       Date:  1985-09       Impact factor: 3.252

9.  Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture.

Authors:  N Frontali; M C Amantini; A Spagnolo; A M Guarcini; M C Saltari; F Brugnone; L Perbellini
Journal:  Clin Toxicol       Date:  1981-12       Impact factor: 4.467

10.  Effects of acute and chronic denervation on release of acetylcholinesterase and its molecular forms in rat diaphragms.

Authors:  J L Cater; S Brimijoin
Journal:  J Neurochem       Date:  1981-03       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.